U.S. Hospitality Stock News

The Morning Bull - US Market Morning Update Wednesday, Dec, 3 2025 US stock futures are pointing modestly higher this morning, with a key economic scorecard, the main US interest rate, expected to be cut by a quarter of a percentage point as early as next week. That potential rate cut signals cheaper borrowing costs for households and businesses, which generally helps growth focused and technology names. At the same time, a second straight weekly drop in US oil inventories, about 2.5 million...

Urban Outfitters, Inc. ( NASDAQ:URBN ) shares have had a really impressive month, gaining 26% after a shaky period...

With the business potentially at an important milestone, we thought we'd take a closer look at Aprea Therapeutics...

Inspired Entertainment, Inc. ( NASDAQ:INSE ), is not the largest company out there, but it received a lot of attention...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Insiders who acquired US$6.90m worth of Hong Kong Pharma Digital Technology Holdings Limited's ( NASDAQ:HKPD ) stock at...

Wingstop Inc. ( NASDAQ:WING ) shareholders are no doubt pleased to see that the share price has bounced 28% in the last...

Key Insights Given the large stake in the stock by institutions, Sera Prognostics' stock price might be vulnerable to...

The fact that multiple Integer Holdings Corporation ( NYSE:ITGR ) insiders offloaded a considerable amount of shares...

Those holding Lifetime Brands, Inc. ( NASDAQ:LCUT ) shares would be relieved that the share price has rebounded 32% in...

Despite an already strong run, Dine Brands Global, Inc. ( NYSE:DIN ) shares have been powering on, with a gain of 26...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Those holding Frontier Group Holdings, Inc. ( NASDAQ:ULCC ) shares would be relieved that the share price has rebounded...

Over the past year, many Lennox International Inc. ( NYSE:LII ) insiders sold a significant stake in the company which...

We can readily understand why investors are attracted to unprofitable companies. For example, VirnetX Holding...

Energy Services of America Corporation ( NASDAQ:ESOA ) shares have had a horrible month, losing 26% after a relatively...

MYR Group's (NASDAQ:MYRG) stock is up by a considerable 18% over the past three months. Given that stock prices are...

If you are wondering whether MannKind at around $5.59 is a hidden opportunity or a value trap, you are not alone, and that is exactly what we are going to unpack. The stock has slipped around 15.3% year to date and 17.8% over the past year, but it is still up 18.9% over 3 years and 98.2% over 5 years, which highlights how sentiment and risk perception have shifted over time. Recent attention on MannKind has centered on its inhaled insulin Afrezza and its expanding footprint in pulmonary...

TC Bancshares (TCBC) has just posted its Q3 2025 numbers, with revenue at about $4.9 million, basic EPS of $0.08 and quarterly net income of roughly $0.33 million, setting the tone for a cautiously constructive update. The company has seen revenue move from around $4.1 million in Q3 2024 to about $4.9 million in Q3 2025, while basic EPS shifted from roughly $0.06 to $0.08 over the same period, giving investors a clearer read on how recent profitability trends are feeding into the latest...

Kura Oncology recently reported that it completed the first U.S. commercial sale of KOMZIFTI (ziftomenib), its newly FDA-approved oral menin inhibitor for adults with relapsed or refractory NPM1‑mutated acute myeloid leukemia, which also triggered a US$135,000,000 milestone payment from partner Kyowa Kirin expected before year-end 2025. This first sale, combined with KOMZIFTI’s inclusion in NCCN guidelines as a Category 2A recommended option, signals early clinical acceptance and provides an...

Wondering whether First Advantage is a bargain or a value trap at today’s price? You are not alone. This article walks through what the numbers are really saying about the stock. The share price has slipped 3.7% over the last week, but it is still up 6.9% over the past month and remains well below where it started the year, down 26.7% year to date and 32.1% over the last 12 months, which has many investors reassessing its risk and reward profile. Recent headlines around tighter labor markets...

Curious whether Standex International's stock is priced for opportunity or risk? You are not alone, and today we are diving into what the numbers really say. The stock has seen a 28.5% gain year-to-date and boasts a 217.5% return over the past five years, reflecting a record of long-term growth. Recent announcements around strategic acquisitions and expansion into new markets have caught investor attention, supporting both recent price momentum and optimism for the company's future...